Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022*

Join Joseph J. Eron, Jr., MD, and Karine Lacombe, MD, PhD, or Babafemi Taiwo, MBBS, and Chloe Orkin, MBChB, FRCP, MD, in a live, interactive, CME/CPE/CE-certified Webinar providing a rapid update and answering your questions on key HIV treatment and prevention studies from IDWeek and HIV Glasgow 2022.

Agenda

Program Overview (5 mins)

Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022 (25 mins)

  • Summary of the most important HIV studies
  • Key clinical practice recommendations

Question and Answer Session (15 mins)

Events

Date / Time
Event Details

Faculty

Faculty
Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Faculty
Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Head, Infectious Diseases Department
St Antoine Hospital, AP-HP
Paris, France

Faculty
Chloe Orkin, MBChB, FRCP, MD

Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, 
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Goal Statement
The goal of this activity is to improve learners’ competence in translating the most clinically significant data from 2 important scientific meetings into practical management strategies for persons at risk of or infected with HIV.

Target Audience
This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients with or at risk of HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
  • Integrate findings on the clinical role(s) of new and investigational ART regimens into an evidence-based foundation for current and future patient care
  • Apply the latest scientific literature to develop and optimize effective HIV prevention strategies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-252-L02-P.

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.